health

Scientists will use the funds in part to develop medications to prevent organ rejection after surgery.

The finding that heart failure is linked to how DNA is packaged within heart cells represents a new way to think about the development of heart disease and its treatment.

Using traditional medical imaging processes the inflammation that sometimes results from immunotherapies can resemble neurological decline and tumor growth.

The findings support the idea that all patients should be discreetly screened for substance abuse during their primary care visits.

UCLA lab led by Nanthia Suthana is the first to study how the brain encodes memory during movement.

A UCLA study finds that few teens do well with less than seven hours a night; more than 11 hours is sub-optimal too.

The study suggests a new possible framework for treating people with familial hypercholesterolemia, an inherited condition characterized by extremely high levels of LDL, the so-called “bad cholesterol.”

UCLA researchers’ study using zebrafish shows how the disease turns a repair mechanism into one that damages nerve cells. The findings could lead to treatments to prevent nerve damage in leprosy and other diseases.

The group’s research will aim to identify new strategies for combating cytomegalovirus, a frequent cause of organ rejection.

Findings from the research, led by UCLA’s Dr. Marco Giovannini, will be used to refine and develop new therapies and treatments, which could benefit young children and adults with these syndromes.

UCLA’s Christopher Childers says the relevant genetic mutations can be easily detected through blood or saliva analysis.

UCLA-led study is the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users.

The injectable hydrogel works by forming a scaffold inside a wound that new tissue can grow around.

The research may lead to new drugs that could promote hair growth for people with baldness or alopecia, which is hair loss linked to such factors such as hormonal imbalance, stress, aging or chemotherapy.

The regimen devised by UCLA researchers has proven to kill cancer cells and eradicate acute lymphoblastic leukemia in mouse models.

Hologram technology developed at UCLA could lead to easier and less costly diagnoses of chronic diseases in remote areas and developing countries.

Teitell, a renowned molecular immunologist and biochemist, was chosen after a national search and assumed leadership on Aug. 8.

The free, six-week program offers students from historically disadvantaged backgrounds classes, training and mentoring.

The survey’s honor roll names only 20 medical centers; UCLA Health has appeared on that list for 28 consecutive years.

The new agency is designed to improve care for people after they have been discharged from the hospital.

Software developed by a UCLA urologist helps men avoid decisions they might regret.

A policy brief by the UCLA Center for Health Policy Research looks at facilities in four U.S. regions, including Los Angeles.

New UCLA resident Razmik Ghukasyan is pursuing a career in surgical oncology with an emphasis on establishing close doctor-patient relationships.

UCLA researchers found that with estrogen therapy for menopause, taking a pill versus wearing a patch on one’s skin doesn’t affect risk or benefit.

Dr. Mayer and a growing number of colleagues at UCLA and around the world who are interested in the mind-gut connection have been buoyed by the emerging evidence coming from studies of the gut microbiome.